Skip to main content
. 2019 Dec 20;10:5806. doi: 10.1038/s41467-019-13646-9

Fig. 7. Treatment responses in anaplastic versus favorable-histology WTPDX.

Fig. 7

The Children’s Oncology Group (COG) EE-4A regimen is modeled by the vincristine and actinomycin-D 2-drug combination treatment, and the COG DD-4A regimen is modeled by the vincristine, actinomycin-D, and doxorubicin 3-drug combination treatment. RTV—median relative tumor volume (cm3).